Skip to main content
Premium Trial:

Request an Annual Quote

Roche to Buy up to $2B of Notes

NEW YORK – Roche said on Tuesday it has commenced a tender offer to purchase for cash a combined aggregate purchase price of up to $2 billion of certain notes.

The notes being purchased include 7 percent notes due 2039; 3.35 percent notes due 2024; 3.25 percent notes due 2023; 3 percent notes due 2025; 2.875 percent notes due 2021; and 5.25 percent senior notes due 2035. All notes are being offered by Roche except the 5.25 percent notes due 2035, which are being issued by Roche subsidiary Genentech.

The amounts to be purchased will be determined in accordance with the acceptance priority level determined by Roche. The amount of the 7 percent notes due 2039 will not exceed an aggregate purchase price of acceptance sublimit of $300 million, Roche said.

The offer will expire at 11:59 p.m. EDT on Dec. 17. JP Morgan Securities and Barclays Capital are the deal managers for the offer.

The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.